Glutamic acid decarboxylase (GAD) is the main target of humoral autoimmunity in patients with insulin-dependent diabetes mellitus (IDDM) and stiff-person syndrome. Wereviewed the case of a 46-year-old womanwhohad cerebellar ataxia before getting stiff-person syndromeand IDDMwith high anti-GAD autoantibody titers. This was a rare case in which there were both the clinical symptomsof stiff-person syndromeand cerebellar ataxia. In western blot analysis her serum reacted with 65-kDa proteins from rat cerebellum, cerebral cortex, and spinal cord. Autoantibodies to GADmay cause functional impairment of y-aminobutyric acid (GABA)neurons in the spinal cord as well as in the cerebellum. (Internal Medicine 40: 968-971, 2001) 
Introduction
Glutamic acid decarboxylase (GAD)catalyzes the conversion of glutamic acid to y-aminobutyric acid (GABA).AntiGADautoantibodies (anti-GAD-Abs) are present in stiff-person syndrome(SPS), polyendocrine autoimmunesyndrome, and insulin-dependent diabetes mellitus (IDDM) (1). Several reports have described the association between progressive cerebellar ataxia and anti-GAD-Abs (2-7), but only two have dealt with patients with anti-GAD-Abs who had both SPS and cerebellar ataxia. Anti-GAD-Abswas postulated to lead to commonfunctional impairment of GABA-nergic synaptic transmission in the spinal cords of patients with SPS and in the cerebellum of patients with cerebellar ataxia. Wereported the case of a 46-year-old womanwho developed SPS and IDDM ten years after the onset of cerebellar ataxia.
Case Report
A 46-year-old Japanese womanexperienced clumsiness of the right hand in August 1988 and two months later developed dysarthria. Her condition gradually worsened over the next ten years. Cerebellar ataxia was diagnosed because of her right upper extremity ataxia and slurred speech. Magnetic resonance imaging (MRI) showed mild cerebellar atrophy (Fig. 1A) . In 1998, she complained of severe trunk stiffness with board-like rigidity of the abdomen and painful muscle spasms, but there was no rigidity of the extremities. In 2000, she suffered polyuria and dry mouth. DMwas diagnosed because of her high fast blood glucose and glycosylated hemoglobin Alc (HbAlc) levels. There was no family history of cerebellar ataxia or IDDM. A neurological examination showed mild dysmetria and dysdiadochokinesia of the right upper limb. Her speech was slurred. The saccadic eye movements were slowed. Muscle strength was almost normal, and her deep tendon reflexes were moderately hyperactive, but pathological reflexes were absent. A complete blood cell count and routine blood biochemical analysis results were in the normal range, except that blood sugar which was 372 mg/dl and HbA]c 12.4% (normal: 4.3-5.8). Serological test showedan anti-GAD-Abstiter of 192,900 U/ml (normal: <5 U/ml). Islet-cell autoantibody and gastric parietal-cell antibody were detected. No other immunological abnormalities were found. Insulin secretion was not induced by an intravenous glucagon injection; the respective serum level of C-peptide immunoreactivity before and 6 minutes after glucagon (1 mg) injection being <0.1 and <0.1 ng/ml. The CSF had a anti-GAD-Abs titer of 396 U//. Anti-Yo antibody and anti-Hu antibody were not detected. Gene analysis for familial spinocerebellar ataxia (SCA1, 2, 3, 6, 8) found no abnormalities. MRIshowed asymmetric cerebellar atrophy of the right hemisphere, but no brainstem atrophy (Fig. I B ). An electromyographic examination detected continuous motor unit activity of the abdominal muscles at rest. Attempts to relax her did not changethis motor unit activity. Surface electromyographyalso showedcontinuous contraction of the abdominal and paraspinal muscles ( Fig. 2A ). An intravenous injection of 2 mgdiazepam markedly decreased the contraction (Fig. 2B) . Her trunk rigid- ity was treated with oral diazepam, resulting in a dramatic reduction in rigidity and painful spasms. The diazepam treatment was slightly effective in reducing the right upper extremity ataxia. Rat tissue samples were homogenizedin lysis buffer and sonicated. The lysates, corresponding to 100 (ig protein, were suspended in the samevolume of Laemmlisample buffer. Proteins were separated electrophoretically in a 15%polyacryla-mide gel and then blotted on a polyvinylidene difluoride (PVDF)membranesheet. Those boundto the membranewere incubated with the patient's serum (diluted 1:500) and antihuman IgG labeled with horseradish peroxidase (DAKO, Glostrup, Denmark) (diluted 1 : 1 ,000). Antibody was detected with a horseradish peroxidase conjugate substrate kit (Bio-Rad Laboratories, Hercules, California, USA). On western blot analysis, the patient's serum recognized 65 kDa bands from rat cerebral cortex, cerebellum, and spinal cord (Fig. 3) . No bands were detected in the control serum. 67, which share a sequence homology of 65% at the protein level. GADis known to be the only protein specific for the GABA-nergicneuron that acts as an inhibitory neuron in the central nervous system. Up to 30% of patients with SPS have IDDMand up to 65% of SPS patients also have antibodies against GAD-65 and GAD-67 ( 1 , 8) . Anti-GAD-Abs are present in patients with SPS as well as in IDDMpatients, but their titers in SPS are markedly higher than in IDDM. Anti-GADAbs in SPS inhibit the synthesis of GABAand recognize both the conformational and denatured forms of GAD (1 , 7, 8) . These findings support the speculation that there is a difference in the epitope of GADin the two diseases. Recent reports have described the association between anti-GAD-Absand cerebellar ataxia (3, 5) . The patients with cer- Table 1 . Clinical Features of Cerebellar Ataxia with Anti-GAD Antibodies 970 ebellar ataxia studied had very high anti-GAD-Abs titers. Their sera recognized a 65 kDa protein that corresponded to GAD-65 in western blot analysis of rat brain homogenates (3). The functional difference in the anti-GAD-Absin cerebellar ataxia and SPS, however, was not clarified. Ishida et al reported a case of cerebellar ataxia with anti-GAD-Abs. Using a patch cramp technique with rat cerebella, he found that immunoglobulins in the CSF of the patient acted presynaptically causing a selective suppression of GABA-nergictransmission (7). Moreover, experimental evidence showsPurkinje cells rich in GAD may take up IgG from the CSF (9). The high anti-GAD-Abs levels were found in the serum as well as in the CSFof the patients. Anti-GAD-Abs may be internalized to neurons by Purkinje cells and interact with GAD,resulting in cerebellar dy sfunction. Honnorat et al described a patient without IDDMwho had slowly progressive cerebellar ataxia, peripheral neuropathy, and slow saccadic eye movement(2). Saiz et al reported three patients with subacute cerebellar ataxia and IDDM(4). In the report ofAbele et al, one patient who had had progressive cerebellar ataxia for 13 years showed clinical improvement after an intravenous injection of immunoglobulin (6) . Only two reports showedthe presence of a cerebellar disorder at the time of or after the development of SPS (Table 1) (3, 5) . The present report is the first case of stiff-person syndrome occurring ten years after the onset of cerebellar ataxia. The presence of anti-GAD-Absin our patient may be an indication of functional impairment of GABA-nergicneurons in the spinal cord as well as in the cerebellum.
